Contact
- 979.436.9341
- khowell1@tamu.edu
-
212 Adriance Lab Rd., 1266 TAMU
College Station, TX 77843-1266
Education
- PhD, Epidemiology University of Memphis, 2021
- MPH, Epidemiology Emory University, 2018
- BS, Biology University of Oklahoma, 2016
Awards & Honors
- University of Memphis School of Public Health Student Achievement Award, 2021
Websites
Publications
2023 Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease. Hemasphere
Howell KE, Pugh N, Longoria J, Shah N, Kutlar A, Gordeuk VR, King AA, Glassberg J, Kayle M, Melvin C, Treadwell M, Hankins JS, Porter JS. Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease. Hemasphere. 2023 Jul 13;7(8):e930. doi: 10.1097/HS9.0000000000000930. PMID: 37456969; PMCID: PMC10348722.
2023 Health literacy correlates with abbreviated full-scale IQ in adolescent and young adults with sickle cell disease. Pediatr Blood Cancer
Bhatt N, Calhoun C, Howell KE, Jacola L, Longoria J, Kang G, King A, Hankins JS. Health literacy correlates with abbreviated full-scale IQ in adolescent and young adults with sickle cell disease. Pediatr Blood Cancer. 2023 May; 70(5):e30281. doi: 10.1002/pbc.30281. Epub 2023 Mar 2. PMID: 36861391.
2022 Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease. Expert Review Hematology
Howell KE, Heitzer AM, Longoria JN, Potter B, Wang WC, Anderson S, Kang G, Hankins JS, Porter JS. Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease. Expert Review Hematology. 2022 Nov 10. doi: 10.1080/17474086.2022.2144216. Epub ahead of print. PMID: 36356169.
2022 Feasibility of Fitbit Use in Adolescent Survivors of Pediatric Cancer: Who Consistently Uses It and for How Long?
Williamson Lewis R, Howell KE, Effinger KE, Meacham LR, Wasilewski-Masker K, Mertens A, Marchak JG. Feasibility of Fitbit Use in Adolescent Survivors of Pediatric Cancer: Who Consistently Uses It and for How Long? Journal of Adolescent Young Adult Oncology. 2022 Sep 29. doi: 10.1089/jayao.2022.0071. Epub ahead of print. PMID: 36178482.
2021 Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. BMJ Open
Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, Tanabe P, Badawy SM, DiMartino L, Gibson R, Kanter J, Klesges LM, Hankins JS; Sickle Cell Disease Implementation Consortium. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. BMJ Open. 2021 Nov 17;11(11):e050880. doi: 10.1136/bmjopen-2021-050880. PMID: 34789492; PMCID: PMC8601067.
2021 Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease. Pediatric Blood Cancer
Howell KE, Saulsberry-Abate AC, Mathias JG, Porter JS, Hodges JR, Ataga KI, Anderson S, Nolan V, Hankins JS. Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease. Pediatric Blood Cancer. 2021;e29209 https://doi.org/10.1002/pbc.29209.
A Meta-analysis of Toxicities Related to Hydroxycarbamide Dosing Strategies
Mathias JG, Nolan V, Meadows-Taylor M, Robinson LA, Howell KE, Gurney J, Hankins J, Wang W, Estepp J, Smeltzer MP. A Meta-analysis of Toxicities Related to Hydroxycarbamide Dosing Strategies. eJHaem https://doi.org/10.1002/jha2.7.
2020 Global Survey on Molecular Testing in Lung Cancer
Smeltzer MP, Wynes MW, Lantuejoul S, Soo R, Ramalingam SS, VarellaGarcia M, Taylor MM, Richeimer K, Wood K, Howell KE, Dalurzo ML, Felip E, Hollenbeck G, Kerr K, Kim ES, Mathias C, Pacheco J, Postmus P, Powell C, Tsuboi M, Wistuba II, Wakelee HA, Belani CP, Scagliotti GV, Hirsch FR, The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer, Journal of Thoracic Oncology, doi.org/10.1016/j.jtho.2020.05.002.